Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verrica Pharmaceuticals Inc (NQ: VRCA ) 2.080 -0.220 (-9.57%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Verrica Pharmaceuticals Inc < Previous 1 2 3 4 Next > Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month August 27, 2024 Via Benzinga Crude Oil Down Over 1%; Mercury Systems Shares Spike Higher August 14, 2024 Via Benzinga Exposures Fossil Fuels Dow Jumps Over 200 Points; Performance Food Group Shares Gain After Q4 Results August 14, 2024 Via Benzinga Topics Stocks Exposures US Equities VRCA Stock Earnings: Verrica Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 August 14, 2024 VRCA stock results show that Verrica Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace US Stocks Mixed; Inflation Rate Falls More Than Projected August 14, 2024 Via Benzinga Topics Economy Exposures Interest Rates Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Earnings Outlook For Verrica Pharmaceuticals February 28, 2024 Via Benzinga 7 Analysts Have This to Say About Verrica Pharmaceuticals October 12, 2023 Via Benzinga Analyst Ratings for Verrica Pharmaceuticals August 10, 2023 Via Benzinga Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday? August 14, 2024 Verrica Pharmaceuticals shares positive preliminary results from Part 2 of its Phase 2 trial for VP-315 in treating basal cell carcinoma, showing promising tumor reduction and safety. No serious... Via Benzinga 7 Short-Squeeze Stocks That Could Beat Down the Bears July 15, 2024 Panic can be a cruel emotion, especially when the consequences are uncapped red ink. Via InvestorPlace Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday May 14, 2024 Via Benzinga VRCA Stock Earnings: Verrica Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 13, 2024 VRCA stock results show that Verrica Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 7 Potential Short-Squeeze Stocks Poised for Rapid Gains January 22, 2024 Giving the bears a rough time can yield massive gains for contrarians, thus drawing attention to these potential short-squeeze stocks. Via InvestorPlace HC Wainwright & Co. Maintains Buy Rating for Verrica Pharmaceuticals: Here's What You Need To Know July 27, 2023 Via Benzinga Top 4 Health Care Stocks That May Crash This Month December 20, 2023 As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Insiders Buying Pfizer And 3 Other Stocks December 20, 2023 Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. Via Benzinga Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today? December 15, 2023 With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response. Via InvestorPlace Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 15, 2023 Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 15, 2023 Via Benzinga Why Is Skin Disease-Focused Verrica Pharmaceuticals Stock Trading Higher Today? December 15, 2023 Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) development and commercialization partner, Torii Pharmaceutical Co Ltd, reported topline results from its Phase 3 trial of TO-208 (referred to as VP-102 and... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 15, 2023 Via Benzinga Verrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA Approval July 25, 2023 Monday, the FDA approved Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023 July 25, 2023 Via Benzinga Earnings Scheduled For November 9, 2023 November 09, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. Via Benzinga $1M Bet On Verrica Pharmaceuticals? Check Out These 3 Stocks Insiders Are Buying July 25, 2023 Although US stocks closed higher on Monday, there were a few notable insider trades. Via Benzinga Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday July 24, 2023 The company's shares dropped because it will require financing to help launch its first marketed product. Via The Motley Fool Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 24, 2023 Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session July 24, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.